Dianthus Therapeutics is advancing treatments for autoimmune diseases. Read why DNTH stock is receiving Buy ratings and price targets of $40 to $58.

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on ARGX stock, giving a Buy rating yesterday.Stay Ahead of the ...

Samsung Bioepis and Teva have entered into a license, development and commercialization agreement for Epysqli ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on KYTX stock, giving a Buy rating on January 13.Stay Ahead of the ...

There's a lot of brain power that goes into speech. First, there's a thought or idea, which the brain must translate into ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cho0xxI9.js ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

Aristotle Onassis was one of the most famous Greeks in the entire world in the 20th century, a visionary and one of the ...

Here is a closer look at Aristotle Onassis, the Greek business magnate featured in the Netflix film Maria starring Angelina ...